Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.13

-0.09

-0.06

-0.02

Details

Expected EPS

-0.026667

Actual EPS

-0.13

Surprise EPS

-0.1

Surprise Percent

+387.49%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.13 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.